期刊文献+

PSA灰区值时MRI+MRS在早期诊断前列腺癌中临床意义 被引量:2

Role of MRI + MRS in early diagnosis of prostate cancer of PSA gray zone
下载PDF
导出
摘要 目的探讨PSA灰区值时,MRI+MRS在早期诊断前列腺癌中临床意义。方法对92例PSA4-10ng/ml患者行MRI+MRS检查,对MRI异常和(或)MRS检查(胆碱+肌酸)/枸橼酸盐(Cho+Cre/Cit)≥0.75患者进行前列腺穿刺活检,MRI+MRS无异常者,有手术指征行前列腺电切术,术后行病理检查,无手术指征定期随访。结果 73例MRI异常和(或)Cho+Cre/Cit≥0.75穿刺后,12例前列腺癌,其中1例前列腺癌患者MRI示前列腺肿瘤已侵及前列腺包膜,19例MRI+MRS无异常者术后病理1例前列腺癌。阳性组(前列腺癌组)Cho+Cre/Cit值与阴性组(前列腺增生)相比差异显著(P<0.05)。结论 PSA4-10ng/ml前列腺增生患者,常规行MRI+MRS,有助于前列腺癌早期诊断及临床分期,以Cho+Cre/Cit≥1.29为穿刺的最佳临界值,但有待大样本研究进一步证实及界定。 Objective To discuss MRI+MRS clinical significance for the early diagnosis of prostate cancer When PSA in a gray zone. Methods 92 patients whose PSA was 4-10ng/ml underwent MRI+MRS examination,those patients whose MRI(or) MRS was abnormal[(choline+creatine)/citrate(Cho+Cre/Cit)≥0.75] underwent prostate biopsy,other patients whose MRI+MRS was normal underwent transurethral resection of the prostate if they have the operation indications,and pathological examination after opera-tion. We follow up the patients without operation indication. Results 73 patients with Cho+Cre/Cit≥0.75 underwent puncture,12 cases of prostate cancer,One example of prostate cancer MRI showed the tumor has invaded the prostate capsule,and 1 patient of prostate cancer in 19 cases of normal MRI+MRS. Positive group (prostate cancer) Cho+Cre/Cit value and negative (benign prostatic hyperplasia) compared to the significant difference (P〈0.05). Conclusion The patients with PSA4-10ng/ml underwent routine MRI+MRS,which contribute to the early diagnosis of prostate cancer and clinical stage,the best critical value of prostate biopsy is Cho+Cre/Cit≥1.29,but the conclusion must be confirmed and defined through a large sample study further.
出处 《江西医药》 CAS 2014年第11期1127-1130,共4页 Jiangxi Medical Journal
基金 江西省科技计划项目(2011-ZBBG70040)
关键词 前列腺癌 磁共振成像 磁共振波谱 PSA灰区 诊断 Prostate cancer Magnetic resonance imaging(MRI) Magnetic resonance spectroscopy(MRS) PSA in a gray zone Diagnosis
  • 相关文献

参考文献14

二级参考文献73

  • 1邵常霞,项永兵,刘振伟,高静,孙璐,方茹蓉,阮志贤,高立峰,金凡,高玉堂.上海市区泌尿系统恶性肿瘤相对生存率分析[J].中国肿瘤临床,2005,32(6):321-324. 被引量:30
  • 2王希明,白人驹.前列腺癌分子水平成像:MRSI[J].国外医学(临床放射学分册),2005,28(5):340-343. 被引量:1
  • 3曾洪武,王培军.磁共振扩散加权与弥散张量成像原理分析及比较[J].中国医学影像技术,2005,21(12):1945-1947. 被引量:49
  • 4张心如,徐月敏,李涛,黄慕民,唐天雪,陈嵘,金重睿,司捷旻.前列腺特异抗原水平为4~10μg/L的前列腺癌诊断对策[J].临床泌尿外科杂志,2006,21(4):249-251. 被引量:5
  • 5王继琛,高玉洁,蒋学祥,李松年,刘赓年.前列腺癌的MRI诊断与分期[J].中华放射学杂志,1996,30(11):741-744. 被引量:27
  • 6STAMEY TA, YANG N, HAY AR, et al. Prastate-specific antigen as a serum marker for adenocarcinoma of the prostate[J]. N Engl J Med, 1987, 317(15): 909-916.
  • 7THOMPSON IM, ANKERST DP. Prostate-specific antigen in the early, detection of prostate cancer [R]. CMAJ, 2007, 176 (13): 1853-1858.
  • 8LOEB S, CATALONA WJ. Prostate-specific antigen in clinical practice[R]. Cancer Lett, 2007, 249(1): 30-39.
  • 9GREGORIO EP, GRANDO J-P, SAQUETI EE, et al. Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/mL [J]. Int Braz J Urol, 2007, 33(2): 151-160.
  • 10KAWAI M. OKAJIMA K, KOBAYASHI K, et al. Combined use of PSA density and free to total PSA ratio for cancer detection from patients with PSA elevations[J]. Hinyokika Kiyo, 2006, 52 (2): 113-117.

共引文献113

同被引文献14

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部